
New reports suggest diabetes weight loss drugs could reduce Alzheimer's risk
Drugs originally developed to treat type 2 diabetes, particularly GLP-1 receptor agonists such as semaglutide (sold as Ozempic and Wegovy), are now drawing increased attention for their potential to protect brain health. Two recent studies and an editorial …